recognit
pathogenderiv
structur
ctype
lectin
chemotact
activ
mediat
axi
critic
step
determin
host
immun
respons
fungi
present
studi
design
investig
whether
presenc
singl
nucleotid
polymorph
snp
within
dcsign
gene
influenc
risk
develop
invas
pulmonari
aspergillosi
ipa
twentyseven
snp
select
use
hybrid
functionaltag
approach
genotyp
haematolog
patient
fiftyseven
diagnos
proven
probabl
ipa
accord
eortcmsg
criteria
associ
analysi
reveal
carrier
tt
gg
genotyp
dcsign
g
dcsign
dcsign
dcsign
c
allel
significantli
increas
risk
ipa
infect
ci
ci
ci
ci
ci
ci
respect
also
significantli
increas
frequenc
galactomannan
posit
among
patient
carri
allel
genotyp
addit
healthi
individu
latter
genotyp
show
significantli
decreas
level
mrna
express
compar
callel
carrier
suggest
role
polymorph
determin
level
consequ
level
suscept
ipa
infect
snpsnp
interact
epistasi
analysi
reveal
signific
interact
model
includ
snp
gene
synergist
genet
effect
although
result
need
valid
larger
cohort
suggest
dcsign
genet
variant
influenc
risk
ipa
infect
might
use
develop
riskadapt
prophylaxi
invas
pulmonari
aspergillosi
ipa
lifethreaten
infect
caus
mainli
aspergillu
fumigatu
opportunist
fungal
pathogen
frequent
colon
respiratori
tract
rapidli
spread
blood
vessel
tissu
incid
ipa
infect
increas
last
year
due
use
immunosuppress
immunomodulatori
drug
still
caus
signific
morbid
mortal
worldwid
especi
immunosuppress
hematopoiet
stem
cell
transplant
hsct
patient
earli
recognit
fumigatu
myeloid
leukocyt
crucial
downstream
immun
respons
conidia
clearanc
therefor
develop
progress
ipa
infect
myeloid
leukocyt
activ
patternrecognit
receptor
prr
directli
recogn
fungal
cell
wall
structur
pathogenassoci
molecular
pattern
pamp
among
prr
express
neutrophil
pulmonari
macrophag
dendrit
cell
ctype
lectin
famili
member
dcsign
dendrit
cellspecif
intercellular
adhes
nonintegrin
dendrit
cellassoci
ctype
dendrit
cellassoci
ctype
seem
import
effect
innat
immun
respons
fumigatu
recent
studi
report
ctype
lectin
mediat
fumigatu
recognit
captur
intern
bind
fungal
cell
wall
carbohydr
highli
specif
select
dcsign
recogn
b
glucan
galactomannan
gm
cell
wall
fumigatu
interact
amannan
howev
numer
studi
shown
ctype
lectin
involv
recognit
fungal
pathogen
also
induct
antifung
immun
respons
although
mechan
underli
dcsignmedi
immun
respons
still
highli
specul
suggest
dcsign
promot
dendrit
cell
dc
migrat
tcell
activ
bind
modul
tlr
signal
target
regul
nfkb
activ
consequ
product
proinflammatori
cytokin
likewis
induc
sykdepend
canon
noncanon
nfkb
pathway
promot
product
proinflammatori
cytokin
chemokin
neutrophil
recruit
also
describ
abl
work
collabor
tlr
mainli
modul
immun
respons
product
tnf
find
support
hypothesi
ctype
lectin
cytokin
chemokin
import
mediat
infect
fumigatu
sever
polymorph
human
prr
well
cytokin
chemokin
receptor
hitherto
associ
increas
risk
invas
aspergillosi
suscept
host
base
observ
object
present
studi
investig
role
tag
potenti
function
singlenucleotid
polymorph
snp
locat
within
dcsign
gene
ipa
suscept
particip
enrol
caucasian
recruit
univers
hospit
virgen
de
la
niev
granada
spain
univers
hospit
salamanca
salamanca
spain
determin
genet
analys
hematolog
patient
perform
fulli
inform
written
consent
anonym
data
guarante
studi
protocol
approv
ethic
review
committe
virgen
de
la
niev
univers
hospit
granada
spain
popul
includ
hematolog
patient
recruit
januari
januari
hematolog
patient
studi
receiv
prolong
chemotherapi
treatment
underw
hsct
therefor
consid
suscept
develop
ipa
infect
demograph
inform
clinic
data
obtain
detail
review
hospit
record
data
gather
site
infect
host
factor
criteria
sever
neutropenia
day
persist
fever
h
refractori
appropri
broadspectrum
antibacteri
treatment
sign
symptom
indic
graftversushost
diseas
gvhd
corticoid
therapi
mgkg
per
day
invas
fungal
infect
previou
episod
neutropenia
microbiolog
criteria
posit
result
aspergillu
antigen
consecut
blood
sampl
consid
index
sampl
index
higher
clinic
criteria
lower
respiratori
tract
infect
major
criteria
follow
new
infiltr
comput
tomographi
ct
imag
halo
sign
aircresc
sign
caviti
within
area
consolid
minor
criteria
cough
thorac
pain
hemoptysi
patholog
pulmonari
sound
radiolog
evid
suggest
invas
infect
laboratori
data
also
record
proven
probabl
ipa
diagnos
base
updat
criteria
report
european
organ
research
treatment
cancerinvas
fungal
infect
cooper
group
eortc
ificg
serum
gm
detect
shown
use
test
earli
diagnosi
followup
ipa
includ
ipa
diagnosi
criteria
present
studi
serum
gm
antigen
determin
twice
weekli
hospit
stay
outpati
visit
end
immunosuppress
chemotherapeut
treatment
serum
gm
concentr
determin
platelia
aspergillu
elisa
kit
biorad
marneslacoquett
franc
accord
manufactur
instruct
commerci
kit
proven
offer
good
sensit
detect
gm
gm
concentr
found
correl
fungal
tissu
burden
test
sampl
classifi
posit
optic
densiti
ratio
two
consecut
posit
sampl
uniqu
serum
sampl
care
review
concomit
treatment
piperacillintazobactam
amoxicillinclavulon
acid
patient
necessari
detect
possibl
falseposit
gm
determin
likewis
test
perform
day
avoid
sampl
contamin
ensur
accuraci
result
twentyseven
taggingfunct
snp
within
dcsign
select
genotyp
entir
panel
individu
tabl
aim
snp
tag
identifi
set
snp
effici
tag
known
snp
function
approach
use
determin
net
impact
potenti
function
variant
within
dcsign
gene
ipa
risk
tag
snp
select
use
haploview
tagger
program
http
wwwbroadmitedu
mpghaploview
http
wwwbroadmitedumpgtagg
pairwis
tag
minimum
select
forc
inclus
dcsign
polymorph
function
suggest
genom
dna
extract
peripher
blood
mononuclear
cell
pbmc
qiagen
mini
kit
qiagen
valencia
ca
usa
genotyp
dcsign
polymorph
carri
use
kaspar
assay
kbioscienc
hoddesdon
hertfordshir
uk
plate
format
appli
biosystem
foster
citi
ca
usa
hematolog
patient
sampl
randomli
distribut
kaspar
reaction
perform
use
kaspar
assay
mix
contain
probe
kaspar
kit
contain
reaction
mix
mm
pcr
condit
denatur
min
cycl
denatur
sec
anneal
sec
elong
sec
cycl
denatur
sec
anneal
sec
elong
sec
recycl
condit
sec
anneal
elong
sec
pcr
product
analyz
abi
prism
detect
system
use
sd
softwar
appli
biosystem
intern
qualiti
control
sampl
randomli
select
includ
duplic
concord
origin
duplic
sampl
snp
analyz
call
rate
snp
except
snp
call
rate
hardyweinberg
equilibrium
hwe
test
perform
control
group
nonipa
patient
standard
observedexpect
chisquar
x
test
polymorph
site
http
uncondit
logist
regress
use
assess
main
effect
genet
polymorph
ipa
risk
use
codomin
domin
recess
inherit
model
snp
common
allel
control
group
assign
refer
categori
analys
adjust
age
gender
hematolog
malign
establish
risk
factor
ipa
infect
hsct
neutropenia
gvhd
corticoid
therapi
use
conduct
use
statist
softwar
ssp
version
spss
inc
chicago
usa
test
consid
statist
signific
p
valu
adjust
multipl
test
carri
follow
conserv
threshold
statist
signific
base
revis
version
bonferroni
method
calcul
gene
number
effect
independ
variabl
eff
use
snp
spectral
decomposit
approach
http
gumpqimr
eduaugeneraldalensnpspdsuperlit
obtain
studywis
eff
valu
ad
gene
eff
snptool
http
wwwdkfzdedemolgenepidemiologytool
snptoolhtml
haploview
softwar
use
ld
block
reconstruct
haplotyp
associ
statist
block
structur
determin
accord
method
gabriel
et
al
use
webbas
tool
fastsnp
avail
http
fastsnpibmssinicaedutw
predict
function
signific
snp
associ
ipa
infect
fastsnp
util
inform
anoth
onlin
program
polyphen
http
www
borkemblheidelbergdepolyphen
four
differ
web
resourc
tfsearch
esefind
rescuees
fasess
determin
whether
snp
locat
exon
splice
regulatori
site
caus
nonconserv
amino
acid
chang
whether
alter
transcript
factorbind
site
gene
instanc
act
intron
enhanc
score
given
tool
basi
level
risk
rank
effect
low
low
medium
high
high
whole
blood
sampl
healthi
donor
collect
paxgen
rna
tube
store
use
total
rna
extract
use
paxgen
blood
rna
isol
kit
preanalytix
revers
transcrib
cdna
use
quantitect
revers
transcript
kit
catalog
number
qiagen
realtim
quantit
pcr
carri
use
abi
prismh
ht
sequenc
detect
system
appli
biosystem
accord
manufactur
instruct
briefli
ml
cdna
load
pcr
reaction
contain
ml
quantitect
sybr
green
pcr
master
mix
appropri
concentr
mgcl
ml
primer
quantitect
primer
assay
catalog
number
geneglob
qiagen
ml
rnasefre
water
pcr
cycl
condit
follow
minut
follow
cycl
denatur
second
combin
anneal
second
extens
second
sampl
run
duplic
rel
quantif
mrna
express
calcul
method
obtain
fold
chang
gene
express
normal
intern
control
gene
gapdh
quantitect
primer
assay
catalog
number
qiagen
rel
one
calibr
first
also
analyz
highord
interact
snp
use
multifactor
dimension
reduct
mdr
construct
induct
algorithm
detail
explan
mdr
method
describ
elsewher
snp
ld
cutoff
r
exclud
mdr
analysi
crossvalid
permut
test
use
identifi
best
model
possibl
two
threeand
fourway
snp
interact
test
use
crossvalid
exhaust
search
model
highest
test
balanc
accuraci
ta
cross
valid
consist
cvc
select
best
model
statist
signific
evalu
use
permut
test
compar
observ
test
balanc
accuraci
expect
null
hypothesi
associ
use
mdr
permut
test
modul
alpha
mdr
result
consid
statist
signific
level
final
interact
visual
construct
interact
dendrogram
accord
method
describ
moor
et
al
mdr
softwar
mdr
permut
test
modul
opensourc
freeli
avail
http
wwwepistasisorg
popul
characterist
describ
tabl
compar
nonipa
ipa
case
like
cough
patholog
pulmonari
sound
respect
present
often
patholog
chest
radiographi
ct
scan
establish
risk
factor
ipa
infect
hsct
neutropenia
gvhd
corticoid
therapi
use
homogen
distribut
ipa
nonipa
patient
group
fiftyseven
patient
diagnos
proven
probabl
ipa
infect
accord
revis
eortcmsg
criteria
associ
risk
ipa
infect
individu
snp
ctype
lectin
chemokin
gene
shown
tabl
analyz
polymorph
fulfil
hardyweinberg
expect
control
group
nonipa
patient
sever
polymorph
found
associ
ipa
infect
tabl
tabl
tabl
correct
multipl
test
use
snpspd
number
independ
marker
loci
p
none
snp
retain
signific
although
show
signific
carrier
statu
analyz
cccg
vs
gg
p
tabl
order
assess
degre
select
snp
posit
gm
correl
also
perform
lineal
regress
analysi
whole
popul
assay
perform
duplic
consid
posit
found
significantli
higher
percentag
posit
gm
among
patient
carri
allel
among
patient
bear
genotyp
suggest
role
polymorph
determin
defect
recognit
clearanc
aspergillu
conidia
figur
correl
observ
polymorph
within
dcsign
associ
infect
subsequ
assess
whether
snp
associ
ipa
infect
show
capac
chang
put
transcript
factor
bind
site
use
fastsnp
predict
function
analysi
suggest
intron
enhanc
function
snp
due
locat
transcript
factor
cdxa
caudal
type
homeobox
transcript
factor
bind
site
gaaagac
score
data
suggest
central
role
suscept
ipa
infect
none
remain
snp
associ
ipa
infect
predict
affect
transcript
factor
bind
site
splice
introduc
damag
amino
acid
chang
explor
potenti
consequ
snp
mrna
express
measur
healthi
donor
correl
genotyp
result
show
subject
harbour
gg
genotyp
show
significantli
decreas
level
mrna
express
compar
callel
carrier
figur
result
support
hypothesi
suggest
allel
may
disrupt
bind
site
potenti
transcript
factor
mdr
analysi
snp
test
reveal
statist
signific
interact
two
snp
exclud
mdr
analysi
ld
snp
use
cutoff
valu
r
sampl
set
best
interact
model
select
turf
filter
algorithm
along
test
accuraci
crossvalid
consist
shown
tabl
overal
best
model
highest
crossvalid
consist
cvc
consist
model
includ
snp
model
signific
test
accuraci
permut
crossvalid
consist
note
two
snp
show
genet
interact
model
significantli
associ
increas
risk
ipa
infect
univari
analysi
best
twolocu
model
consist
dcsign
snp
two
variant
show
also
associ
singlelocu
analysi
model
test
accuraci
crossvalid
consist
model
signific
permut
test
howev
entropi
base
inform
gain
calcul
pair
snp
indic
strong
synergi
may
interpret
two
snp
act
togeth
increas
risk
ipa
infect
best
threelocu
model
includ
snp
model
test
accuraci
rais
permut
p
wherea
crossvalid
consist
figur
illustr
interact
dendogram
summar
estim
interact
mark
differ
suscept
ipa
infect
among
hematolog
patient
without
allohsct
suggest
effect
immun
respons
aspergillu
determin
environment
host
genet
factor
studi
genet
polymorph
gene
code
compon
innat
immun
support
hypothesi
report
studi
influenc
tag
potenti
function
polymorph
dcsign
suscept
ipa
infect
spanish
popul
polymorph
gene
report
influenc
number
infecti
diseas
includ
cmv
tuberculosi
hcv
hbv
dengu
sar
among
other
reveal
potenti
role
host
defens
pathogen
found
polymorph
dcsign
associ
increas
risk
develop
ipa
infect
point
toward
critic
involv
pathogenesi
invas
fungal
infect
highest
risk
ipa
infect
found
carrier
genotyp
dcsign
allel
patient
carri
genotypesallel
time
increas
risk
ipa
infect
addit
patient
carri
dcsign
dcsign
dcsign
allel
show
increas
risk
comparison
patient
harbor
wildtyp
allel
although
statist
signific
also
found
dcsign
snp
may
associ
reduc
risk
ipa
infect
interestingli
latter
result
agreement
previous
report
find
use
former
eortcmsg
classif
criteria
appar
effect
snp
ipa
suscept
persist
even
adjust
age
gender
hematolog
malign
sever
known
risk
factor
hsct
neutropenia
gvhd
corticoid
therapi
use
indic
dcsign
variant
contribut
independ
risk
infect
anoth
interest
find
studi
significantli
greater
posit
gm
percentag
patient
carri
allel
wildtyp
allel
addit
patient
harbor
gg
genotyp
snp
show
increas
percentag
posit
gm
compar
carri
c
allel
cccg
differ
found
posit
gm
determin
correl
dcsign
polymorph
data
along
remark
degre
associ
dcsign
variant
risk
ipa
infect
provid
compel
evid
critic
role
prr
immun
respons
ipa
infect
regard
numer
studi
shown
dcsign
involv
recognit
fungal
pathogen
also
induct
antifung
immun
respons
mezger
et
al
also
demonstr
involv
induct
sever
proinflamatori
cytokin
chemokin
immun
receptor
werner
et
al
show
also
regul
immun
respons
lung
furthermor
dennehi
brown
suggest
role
mediat
signal
well
synerg
tlr
trigger
nfkbmediat
immun
respons
fungal
pathogen
although
well
recogn
snp
gene
modul
immun
respons
like
determin
host
suscept
fungal
infect
far
littl
known
regard
biolog
signific
variant
order
shed
light
potenti
function
dcsign
variant
investig
whether
involv
disrupt
bind
site
critic
transcript
factor
might
influenc
transcript
level
gene
predict
analysi
show
carriag
c
allel
snp
creat
put
bind
site
cdxa
rel
unknown
transcript
factor
might
involv
control
gene
express
assess
whether
polymorph
might
associ
decreas
express
correl
mrna
express
level
genotyp
interestingli
observ
individu
harbour
gg
genotyp
show
rel
lower
express
carri
c
allel
ccgc
result
support
hypothesi
suggest
snp
may
effect
recognit
aspergillu
conidia
subsequ
immun
respons
howev
predict
chang
transcript
activ
suggest
stage
need
valid
use
vitro
function
assay
sever
line
evid
point
relev
epistat
effect
etiolog
complex
diseas
studi
carri
analyz
presenc
snpsnp
interact
ipa
infect
reason
decid
assess
interact
among
genet
polymorph
within
dcsign
gene
risk
ipa
infect
mdr
approach
use
studi
abl
determin
two
multilocu
combin
associ
high
risk
develop
ipa
infect
interact
identifi
mdr
indic
type
interact
two
signific
model
synergist
result
support
hypothesi
multipl
snpsnp
interact
may
play
role
determin
risk
ipa
infect
hypothesi
biolog
plausibl
sinc
immun
system
would
warrant
prevent
fungal
infect
even
genet
variant
present
recent
populationbas
studi
even
led
identif
sever
snp
involv
earli
recognit
aspergillu
associ
increas
risk
invas
fungal
infect
previous
suggest
snp
within
ctype
lectin
gene
associ
fungal
infect
platinga
et
al
cunha
et
al
suggest
patient
carri
polymorph
gene
like
colon
aspergillu
candida
speci
compar
harbor
wildtyp
allel
howev
result
replic
recent
studi
studi
find
neither
evidenc
even
hsct
nonhsct
patient
analyz
separ
data
shown
puzzl
find
suggest
although
intron
polymorph
within
dcsign
inde
strong
indic
gene
play
import
role
suscept
ipa
infect
rule
figur
interact
dendrogram
gener
mdr
softwar
interact
dendrogram
use
confirm
visual
interpret
interact
model
mdr
analysi
perform
use
opensourc
mdr
softwar
packag
color
use
depict
degre
synergi
rang
red
highest
inform
gain
blue
highest
inform
redund
note
interact
dcsign
snp
show
highest
degre
synergi
gain
inform
possibl
snp
part
bigger
haplotyp
contain
import
genet
variant
neighbor
gene
case
populationbas
studi
conduct
use
rel
small
cohort
addit
studi
larger
set
patient
need
definit
establish
role
variant
suscept
invas
fungal
infect
summari
studi
provid
evid
associ
dcsign
polymorph
risk
ipa
infect
inclus
function
predict
analys
correl
genotyp
posit
gm
determin
mrna
express
level
studi
strongli
support
role
gene
variant
determin
suscept
ipa
infect
epistat
analys
also
suggest
presenc
genegen
interact
involv
variant
determin
ipa
infect
despit
evid
addit
studi
use
larger
cohort
necessari
confirm
effect
polymorph
suscept
ipa
infect
tabl
associ
polymorph
involv
phagocyteimmun
relat
respons
aspergillu
model
adjust
age
gender
hematolog
malign
hsct
neutropenia
defin
absolut
neutrophil
count
period
day
gvhd
corticoid
therapi
use
mgkgday
assum
recess
model
inherit
abbrevi
odd
ratio
ci
confid
interv
differ
sampl
number
due
failur
genotyp
doc
